Jonathan Richman is a respected e-marketer and the author of Dose of Digital blog, in which he writes there is a Myth of Adverse Event Reporting in pharma marketing. Drawing upon a Nielsen Study which found that only 1 in 500 postings on the Yahoo Health discussion boards met the full criteria for adverse event reporting, pharma may in fact be over-sensitized to the issue. Do AER staffing requirements prevent social media dialogue? Read more »
John Mack of the Pharma Marketing Blog hosted a fascinating, by invitation only conference call today to discuss the first-ever pharma branded Tweet for Novo Nordisk’s Levemir™. Never one to mince words, Mack suggested in the invitation that: Novo Nordisk’s Branded (Levemir) Tweet is Sleazy Twitter Spam!. Novo Nordisk Selectively Copies & Edits Kimball’s Tweets. Read more »
We advise clients to ALWAYS “register an account on Twitter for both the brand and company well in advance of needing it for crisis communications.” You don’t even have to use it, just be prepared. It’s like putting batteries in the smoke detector: it’s no fun climbing the ladder to do it, but you’ll be grateful at 3AM when it alerts you. So it’s interesting to note that Twitter is experimenting with “Verified Accounts” which promise the imprint of authenticity on a user’s Tweets. Does this really matter? Consider: Exxon – brand jacked by “Janet” who tweets as the putative spokeswoman for Exxon-Mobil “@1WineDude, did you know that the Valdez spill wasn’t even one of the top 10 worst spills in history? Read more »
“Signal to Noise” refers to the ratio between the desired signal – music for example – to noise like static and hiss. On your iPod, you want more signal and less noise. And according Brian Roy, president and founder of Cosinity a firm creating communications applications Social Media is suffering from a lot of noise. Read more »
Patients and physicians are increasingly relying upon digital word of mouth – Twitter, YouTube, Facebook – for their peer-to-peer information. Separating buzzwords from actionable data is a daunting task. Eularis, a pharmaceutical analytics consultancy focusing on “data-driven decisions” has announced a new report on eMarketing in the age of social media. Key content includes: Pharma Internet Marketing Today, Past and Present. Read more »